Skip to content

A Low FODMAPs Diet in Celiac Patients With Persistent Gastrointestinal Symptoms

The Efficacy of a Low FODMAPs (Fermentable Oligo- di- and Monosaccharides and Polyols) Diet in Celiac Patients With Persistent Gastrointestinal Symptoms

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02946827
Enrollment
68
Registered
2016-10-27
Start date
2016-01-31
Completion date
2017-01-31
Last updated
2016-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Celiac Disease

Keywords

FODMAPs diet, micro-macro nutrients intake, IBS (Irritable Bowel Syndrome)

Brief summary

FODMAPS (fructose, oligosaccharides, monosaccharides, disaccharides and polyols) are characterised as fermentable but poorly absorbed carbohydrates which enter the colon and are utilised by colonic bacteria. During fasting colonic nutrients are scarce but ingesting FODMAPS causes a rapid increase in carbohydrate which can overwhelm the microbiota's ability to utilise substrate. The excess reducing equivalents will generate hydrogen or methane. The principal symptoms are diarrhoea and abdominal distension. Patients with irritable bowel syndrome appear to benefit by restricting intake, possibly because they are hypersensitive to intestinal distension. The focus of the study is to evaluate if in celiac patients with persistent abdominal symptoms and with a correct gluten free diet, a low FODMAPs diet can improve their symptoms. Moreover the study would like to observe if a dietary restriction in FODMAPs carries the risk of nutritional inadequacy.

Interventions

DIETARY_SUPPLEMENTBalanced low FODMAPs /gluten free diet
DIETARY_SUPPLEMENTBalanced gluten free diet

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Celiac patients assessed through positive serology and histology * functional patients according IBS Roma III criteria * subjects with VAS\>5

Exclusion criteria

* refractory celiac disease * disaccharide intolerance (fructose an lactose breath test) * abdominal surgery * comorbidity * patients recruited in other clinical trials * positive patients at lactulose breath test (SIBO)

Design outcomes

Primary

MeasureTime frame
Improvement of VAS (psychometric response scale level continuous line between two end-points 0-10) values of globel well-being in patients undergoing a balanced Gluten Free/low FODMAPs diet compared to patients in balanced gluten free diet.21 days

Secondary

MeasureTime frameDescription
Improvement of VAS values of IBS symptoms in patients undergoing a balanced Gluten Free/low FODMAPs diet compared to patients undergoing only a balanced gluten free diet.21 daysEvaluated IBS symptoms are: abdominal pain, bloating, satisfaction with stool consistency, epigastric pain, postprandial fullness, early satiety.
Improvement of quality of life assessed through SF-36 questionnaire (eight scale scores) in patients undergoing a balanced Gluten Free/low FODMAPs diet compared to patients undergoing only a balanced gluten free diet.21 days
Improvement of psychological problems and symptoms of psychopathology through the symptom checklist 90 R (SCL 90 R) in patients undergoing a balanced Gluten Free/low FODMAPs diet compared to patients undergoing only a balanced gluten free diet.21 days
Evaluation of the dietary intake in micro and macro-nutrients before and after a Low FODMAP diet or a balanced Gluten Free diet through questionnaire.21 days

Countries

Italy

Contacts

Primary ContactLeda Roncoroni, BS PhD
leda.roncoroni@unimi.it+39025503384
Backup ContactLeda Roncoroni
leda.roncoroni@unimi.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026